24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Memic
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:22
XTEND lays off 10% of workforce after losing 75% of its value since $1.5 billion NYSE debut
17:04
Full list of Israeli startup M&As in 2026
17:00
Israeli digital health company TailorMed acquired in $250 million deal
15:41
Marvell acquires Lumentum in $115 billion push to dominate AI connectivity
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
4
Israeli startup Coldi is deploying AI agents to take over the cold call
5
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
More news
Memic
3 stories about Memic
Surgical robotics startup Momentis cutting 60% of team one year after $1 billion SPAC fell through
08.05.23
|
Meir Orbach
Momentis, formerly Memic, which develops robotic-assisted surgery solutions, is laying off 70 of 120 employees
Israeli medical device company Memic to merge with SPAC at more than $1 billion valuation
13.08.21
|
Golan Hazani
Memic is set to merge with Nasdaq-traded MedTech Acquisition Corporation, with the combined company expected to hold approximately $360 million in cash
Israeli medical device company Memic raises $96 million to expand surgical robotic solution
12.04.21
|
Meir Orbach
The funding is set to primarily support commercialization of the Hominis surgical robot in the U.S. following FDA De Novo marketing authorization